We are live on ! Find out more
IXJ icon

iShares Global Healthcare ETF

112.66 USD
+0.92
0.82%
At close Updated Oct 30, 4:00 PM EDT
Pre-market
After hours
112.66
0.00
0%
1 day
0.82%
5 days
2.93%
1 month
10.32%
3 months
11.28%
6 months
21.23%
Year to date
15.28%
1 year
23.4%
5 years
28.75%
10 years
140.06%

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 27.3%
Neutral 54.5%
Negative 18.2%
Neutral
The Motley Fool
4 days ago
Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT?
iShares Global Healthcare ETF offers a lower expense ratio and broader sector exposure than First Trust NYSE Arca Biotechnology Index Fund. First Trust NYSE Arca Biotechnology Index Fund focuses exclusively on biotechnology while iShares Global Healthcare ETF includes pharmaceuticals and equipment.
Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT?
Positive
Zacks Investment Research
7 days ago
Why Healthcare ETFs Are Hovering Around One-Year Highs
Healthcare ETFs are hovering near 52-week highs as earnings prospects improve, clinical breakthroughs advance and GLP-1 demand expands. Explore five ETFs riding the rally.
Why Healthcare ETFs Are Hovering Around One-Year Highs
Neutral
The Motley Fool
24 days ago
IYH Beats IXJ on Returns While Global Fund Offers Higher Yield
iShares Global Healthcare ETF provides broad exposure to international medical companies with a higher dividend yield than its domestic counterpart. iShares U.S. Healthcare ETF concentrates on American companies and has produced higher total returns over the past year and five-year periods.
IYH Beats IXJ on Returns While Global Fund Offers Higher Yield
Negative
Seeking Alpha
1 month ago
IXJ: Healthcare Sector Dashboard For September
Healthcare equipment is undervalued based on historical averages, while other subsectors are slightly overvalued. The iShares Global Healthcare ETF offers diversified global healthcare exposure, with 72% in US companies and 110 holdings. Despite lower company-specific risk and better value, IXJ has underperformed XLV by about 2% annualized over both long and short timeframes.
IXJ: Healthcare Sector Dashboard For September
Neutral
The Motley Fool
1 month ago
Does Fidelity or iShares Have the Better Healthcare ETF For Investors Seeking Broad Exposure?
Fidelity MSCI Health Care Index ETF has a significantly lower expense ratio than iShares Global Healthcare ETF. iShares Global Healthcare ETF provides exposure to international healthcare markets, whereas the Fidelity fund focuses on U.S. equities.
Does Fidelity or iShares Have the Better Healthcare ETF For Investors Seeking Broad Exposure?
Neutral
The Motley Fool
1 month ago
State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors
XLV has a significantly lower expense ratio of 0.08% compared to IXJ's 0.38%. IXJ provides broader exposure with 110 holdings across global markets, while XLV concentrates on 60 domestic S&P 500 stocks.
State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors
Neutral
The Motley Fool
1 month ago
IXJ vs XPH: Global Healthcare ETF or Pharma Focus?
iShares Global Healthcare ETF provides broad sector coverage with a higher dividend yield than State Street SPDR S&P Pharmaceuticals ETF. State Street SPDR S&P Pharmaceuticals ETF has delivered stronger total returns over the last year but experiences significantly higher maximum drawdowns.
IXJ vs XPH: Global Healthcare ETF or Pharma Focus?
Negative
Invezz
1 month ago
KOSPI loses 7,000 in 24 hours as oil and yields hammer Korean stocks
South Korean stocks fell sharply on Thursday as Brent crude held above $100 a barrel, pushing the KOSPI back below the 7,000 mark just a day after it reclaimed the level for the first time in more than a month. The benchmark was down 1.28% at 6,961.23 by late morning in Seoul.
KOSPI loses 7,000 in 24 hours as oil and yields hammer Korean stocks
Neutral
Zacks Investment Research
2 months ago
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
FDA clearance of Lilly and Roche's Alzheimer's blood test highlights a growing diagnostics market and four healthcare ETFs to watch.
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
Positive
The Motley Fool
2 months ago
Which Healthcare ETF Is the Better Buy: Vanguard's VHT or iShares' IXJ?
The Vanguard Health Care ETF (VHT) is significantly cheaper to own than the iShares Global Healthcare ETF (IXJ). IXJ offers exposure to international companies, while VHT focuses more heavily on the U.S. market.
Which Healthcare ETF Is the Better Buy: Vanguard's VHT or iShares' IXJ?
Price charts implemented using Lightweight Charts™